Pure Global AI
Agence sénégalaise de Réglementation pharmaceutique (ARP) market access

Senegal medical device registration resources

Research Agence sénégalaise de Réglementation pharmaceutique (ARP) registration records, classification, regulations, timelines, fees, and market updates — the stable entrance to every Senegal medical device resource.

5 free resources23/25 topics with records5 regulations trackedSep 2026 fees reviewed

Everything we track for Senegal

Browse by resource instead →

Structured regulatory requirements

Explore all 32 source-linked facts

23 of 25 research dimensions currently covered · 12 official sources · latest verification 2026-09-16

Market entry

D01

Authority & regime

Verified
ARP — not the DPM — is the competent authority for medical devices
Device regulation in Senegal is exercised by the Agence sénégalaise de Réglementation pharmaceutique (ARP). Décret n° 2023 2419 never names the Direction de la Pharmacie et du Médicament: i…
1 source-linked fact
Checked 2026-09-16
Open details →
D02

Legal basis & guidance

Verified
Loi n° 2023-06 of 13 June 2023 and Décret n° 2023-2419 of 27 December 2023 form the device legal basis
Senegal's device framework rests on two instruments. Loi n° 2023 06 du 13 juin 2023 relative aux médicaments, aux autres produits de santé et à la pharmacie defines 'produit de santé' to in…
1 source-linked fact
Checked 2026-09-16
Open details →
D03

Device definition & scope

Verified
National definitions of medical device, IVD, accessory, intended purpose and life cycle
Décret n° 2023 2419 is the national instrument that defines the regulated object. Article 1 fixes its scope: manufacture, registration, import, export and distribution of medical devices. A…
1 source-linked fact
Checked 2026-09-16
Open details →
D04

Classification rules

Verified
Senegalese classes A, B, C and D (décret n° 2023-2419)
Classe A — Faible, Classe B — Faible-moyen, Classe C — Moyen-élevé, Classe D — Élevé
1 maintained scheme · 1 related fact
Checked 2026-09-16
Open details →
D05

Registration pathways

Verified
Classes B, C and D need a marketing authorisation; class A is a declaration
The device registration dossier is subject to administrative and technical evaluation, and the registration process results in a marketing authorisation for devices of class B, C and D. Cla…
Class C and D devices need a certificate of putting-into-service before any use
A certificat de mise en service is delivered by the pharmaceutical regulation structure before any use of high risk medical devices, notably those of classes C and D. This is a third author…
3 source-linked facts
Checked 2026-09-16
Open details →
D06

Reliance & recognition

Verified
UEMOA harmonised device dossier makes foreign conformity evidence a mandatory attachment, not a route
statement: The UEMOA device guidelines that Senegal is bound to implement require the marketing authorisation dossier to contain a certified copy of the conformity attestation obtained thro…
Statutory power to recognise foreign vigilance decisions and reports — post-market only, no market access
statement: Senegal's national vigilance system law gives the pharmaceutical regulatory structure an express power to recognise, under predefined conditions, vigilance decisions of other cou…
2 source-linked facts
Checked 2026-09-16
Open details →
D07

Economic-operator roles

Verified
A local representative is mandatory to file; a vigilance officer resident in Senegal is mandatory to hold
The applicant for a device marketing authorisation files with the ARP through its local representative. The UEMOA harmonised framework, which Senegal transposes, requires a manufacturer wis…
1 source-linked fact
Checked 2026-09-16
Open details →
D08

Establishment, import & distribution

Verified
Each device establishment activity needs its own ARP agreement, gated by prior inspection
Establishments or companies whose object concerns medical devices are agreed by decision of the ARP's Director General to carry out wholesale and/or retail distribution of medical devices,…
1 source-linked fact
Checked 2026-09-16
Open details →
D09

Dossier requirements

Verified
The national device dossier contents are not in the decree or the arrêté — they are delegated to unpublished ARP Director-General decisions
The composition of the application dossier for a device marketing authorisation, for a variation, for a renewal, for an import authorisation and for a distribution agreement, and the modali…
1 source-linked fact
Checked 2026-09-16
Open details →
D10

Official forms & portals

Unresolved

No source-verified answer is published for this dimension yet.

0 source-linked facts
Open details →

Submission & evidence

D11

Label, IFU & language

Verified
Technical documentation must be established in the national official language (French)
The manufacturer must establish, in the national official language, the technical documentation required for the conformity assessment, the identification and the use of the medical device,…
1 source-linked fact
Checked 2026-09-16
Open details →
D12

QMS, audit & inspection

Verified
Good-practices compliance duty and official inspection of the device supply chain
Compliance with the good practices in force is made an express statutory duty of medical device manufacturers and distributors: 'Art. 41. Les fabricants et les distributeurs sont tenus au r…
1 source-linked fact
Checked 2026-09-16
Open details →
D13

Standards, testing & ancillary approvals

Unresolved
ARP essential requirements — electromagnetic compatibility
EMC
ARP essential requirements — protection against electrical hazards
Electrical safety
ARTP prior agrément for radioelectrical equipment
Wireless / radio
5 maintained overlays · 4 related facts
Checked 2026-09-16
Open details →
Marketing authorisation — Class D device, registration (enregistrement)
XOF 1,000,000
Marketing authorisation — Class D device, renewal (renouvellement)
XOF 500,000
13 maintained fee lines · 1 related fact
Checked 2026-09-16
Open details →
D15

Review clocks

Verified
Establishment agrément — manufacture, import, registration, export, distribution and maintenance of medical devices · Agrément d'établissement decided by the ARP Director-General (décret n° 2023-2419, art. 28; arrêté, arts. 2-14), after a prior inspection for manufacturing and wholesale-import establishments
3 months
ARSN authorisation — device or installation using ionizing radiation · Autorisation issued by the ARSN under loi n° 2021-44 du 31 décembre 2021, with separate application forms for importation, exportation, détention et utilisation, and transport
15-30 days
2 maintained pathways · 1 related fact
Checked 2026-09-16
Open details →
D16

Approval validity & renewal

Verified
Five-year marketing authorisation; device renewal due 120 days before expiry, establishment agreement six months
The device marketing authorisation for classes B, C and D is valid for five years, renewable. A renewal application for a device marketing authorisation must be filed 120 days before its ex…
1 source-linked fact
Checked 2026-09-16
Open details →

Lifecycle & post-market

D17

Change control

Verified
Any change to a device marketing-authorisation dossier requires a variation request
Any modification of the application dossier for a device marketing authorisation requires a variation request in accordance with the regulations in force; the composition of the variation d…
1 source-linked fact
Checked 2026-09-16
Open details →
D18

UDI, listing & traceability

Verified
Statutory 'listing' of devices plus manufacturer and distributor traceability duties
Senegal's device decree creates a national data collection mechanism called 'listing' and a manufacture to final use traceability duty, but it does not create a UDI issuer or a public UDI d…
1 source-linked fact
Checked 2026-09-16
Open details →
D19

Clinical investigation & performance

Verified
Clinical evaluation for all devices and clinical investigations on human subjects
Décret n° 2023 2419 makes clinical evidence an element of the essential requirements for every medical device. Annexe 1 (the essential requirements, made an integral part of the decree by a…
1 source-linked fact
Checked 2026-09-16
Open details →
D20

Special access & derogation

Verified
Devices supplied for sale or as donations must comply with the decree's essential requirements (Décret 2023-2419, Art. 30)
Medical devices offered for sale or given as donations must comply with the essential requirements of the decree; donation is therefore not a derogation from the safety, quality and perform…
The Law's donation-import and exceptional individual-import derogations (Art. 140-141) are drafted for medicines only; import conditions for other health products are left to a ministerial order (Art. 142)
Loi 2023 06 provides that import/export conditions for donated medicines are fixed by joint order of the Finance and Health Ministers (Art. 140) and that, by derogation from Art. 138, impor…
3 source-linked facts
Checked 2026-09-16
Open details →
D21

Manufacturer PMS

Verified
Manufacturer's continuing post-market reporting, risk-reduction and documentation duties
Décret n° 2023 2419 places continuing post market obligations directly on the medical device manufacturer. The seventh indent of art. 34 requires the manufacturer to 'informer immédiatement…
1 source-linked fact
Checked 2026-09-16
Open details →
D22

Vigilance & incident reporting

Verified
National vigilance system with ARP-hosted organs; matériovigilance is a named component of device post-market surveillance
Matériovigilance is defined in the device decree as the surveillance of incidents linked to the use of medical devices, and the device post market surveillance system comprises import/expor…
1 source-linked fact
Checked 2026-09-16
Open details →
D23

Recall, FSCA & market surveillance

Verified
ARP Director General may suspend or withdraw a device marketing authorisation for public-health danger
Any device marketing authorisation may be suspended. Suspension is imposed for a determined period where there is a suspicion of danger to public health or where the device actually present…
1 source-linked fact
Checked 2026-09-16
Open details →
D24

Advertising, claims & promotion

Verified
Promotion and advertising control as a component of device market surveillance, under the national advertising authorisation regime
Two instruments together govern promotion and advertising of medical devices in Senegal. First, Décret n° 2023 2419 art. 43 makes 'le contrôle de la promotion et de la publicité' an express…
1 source-linked fact
Checked 2026-09-16
Open details →
D25

Submission communications & appeal

Verified
Standing ARP complaints channel, and no dedicated appeal against device regulatory decisions
Senegal provides a general written channel for contesting or commenting on ARP action, but the device decree creates no dedicated appeal against its own decisions. The ARP operates a public…
1 source-linked fact
Checked 2026-09-16
Open details →

Agence sénégalaise de Réglementation pharmaceutique (ARP) registration fees in XOF · reviewed 2026-09-16

Fee lineAmountProvenance
Marketing authorisation — Class D device, registration (enregistrement)XOF 1,000,000Verified
Marketing authorisation — Class D device, renewal (renouvellement)XOF 500,000Verified
Marketing authorisation — Class D device, major variationXOF 1,000,000Verified
Marketing authorisation — Class D device, minor variationXOF 250,000Verified
9 more fee lines on the full schedule · 13 of 13 rows source-verified

Registration timeline

Full registration timeline

Agence sénégalaise de Réglementation pharmaceutique (ARP) (Agence sénégalaise de Réglementation pharmaceutique (ARP)) review clocks and planning ranges · 4-class (A, B, C, D) — IMDRF/WHO model adopted nationally by décret n° 2023-2419, with a separate A/B/C/D table for IVDs classification

Class / pathwayReview clockPlanning totalProvenance
Establishment agrément — manufacture, import, registration, export, distribution and maintenance of medical devices(Agrément d'établissement decided by the ARP Director-General (décret n° 2023-2419, art. 28; arrêté, arts. 2-14), after a prior inspection for manufacturing and wholesale-import establishments)3 months4-6 monthsVerified
ARSN authorisation — device or installation using ionizing radiation(Autorisation issued by the ARSN under loi n° 2021-44 du 31 décembre 2021, with separate application forms for importation, exportation, détention et utilisation, and transport)15-30 days30-60 daysVerified
  1. 1Pre-Submission Preparation(1-3 months)
  2. 2Application Submission(1-2 weeks)
  3. 3Administrative Review(2-4 weeks)
  4. 4Technical Evaluation(3 months)
  5. 5Registration Approval(1-2 weeks)

Official Agence sénégalaise de Réglementation pharmaceutique (ARP) rules and guidance · 5 of 5 documents linked to official sources

Décret n° 2023-2419Décret n° 2023-2419 du 27 décembre 2023 fixant les conditions de fabrication, d'importation, d'enregistrement, d'exportation et de distribution des dispositifs médicaux
RegistrationVerified
Décret n° 2023-2423Décret n° 2023-2423 du 27 décembre 2023 instituant le système national de vigilances
VigilanceVerified
Décret n° 2025-1833Décret n° 2025-1833 du 18 novembre 2025 fixant les redevances issues de la régulation du secteur pharmaceutique et leurs modalités de perception
GeneralVerified
ECOWAS Joint Assessment Procedure (ECOWAS JAP)ECOWAS Joint Assessment Procedure (ECOWAS JAP) for medicine registration and marketing authorization of medicinal products
GeneralVerified
Continue with this market

Turn Senegal research into practical work

The target market is carried into each tool. Add the product, evidence, or regulatory change you want to assess.

View every AI workpaper →
Country hubs in other markets

Other Middle East & Africa markets

DJ Fang
Entering the Senegal market?
Local representation, Agence sénégalaise de Réglementation pharmaceutique (ARP) submissions, and lifecycle maintenance — handled with an expert.
Pricing